Products

Novetide has a wide range of commercially available peptide products and a robust pipeline of products in development. As part of the product development and commercialization we provide global registration and customer support. We continue to work with you pre- and post commercialization to provide industrial scale production and any necessary follow-up regulatory support.

*This is only a selection of the products offered by Novetide and does not include a list of proprietary products currently being developed and manufactured by Novetide

Product Name	Therapeutic Category	DMF / CEP	New / Commercial
Atosiban Acetate	Hormones - labour inhibitors - oxytocin receptor antagonist	EU DMF	Commercial
Bivalirudin	Antithrombotic - direct thrombin inhibitor	US DMF, EU DMF, Canada DMF, India DMF	New
Desmopressin acetate	Urinary incontinence and retention - vasopressins	US DMF, CEP, Japan DMF	Commercial
Eptifibatide	Antithrombotic - glycoprotein inhibitors	Canada DMF, US DMF, EU DMF	New
Exenatide	Antidiabetic - glucagon-like peptide 1 receptor agonist	US DMF, EU DMF	New
Lanreotide acetate	Antineoplastic agents - hormonal - somatostatin analog		New
Leuprolide (leuprorelin acetate)	Antineoplastic agent - hormonal - LHRH agonist	US DMF, Canada DMF, EU CEP, Japan DMF	Commercial
Octreotide Acetate	Antineoplastic agents - hormonal - somatostatin analog	US DMF, EU DMF, Korea DMF	Commercial
Pramlintide Acetate	Antidiabetic - amylin analogue		New
Teriparatide acetate	Bone disease - bone resorption inhibitor		New
Triptorelin pamoate	Antineoplastic agents - hormonal - gnrh agonist		New